Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Oct;15 Suppl 4(Suppl4):S337-44.
doi: 10.4103/2230-8210.86977.

Implications and considerations during pheochromocytoma resection: A challenge to the anesthesiologist

Affiliations

Implications and considerations during pheochromocytoma resection: A challenge to the anesthesiologist

Sukhminderjit Singh Bajwa et al. Indian J Endocrinol Metab. 2011 Oct.

Abstract

Pheochromocytoma is a rare catecholamine secreting tumor arising commonly from adrenal medulla. It has got multidimensional challenging aspects in spite of our improved understanding of its physiological and clinical behavior during surgical resection. This neuroendocrine tumor is associated with a most unpredictable and fluctuating clinical course during anesthesia and surgical intervention. The clinical difficulties and challenges increase manifold in patients with undiagnosed or accidental diagnosis of pheochromocytoma who present to the hospital for the treatment of some other disease or emergency. The most common manifestations of this clinical spectrum include hypertension, headache, palpitations, episodic sweating, and feeling of doom. The definite and only treatment for this rare tumor is surgical resection which itself is very challenging for an anesthesiologist. This article reviews the pre-operative evaluation, pharmacological preparation, intraoperative and post-operative management of patients with pheochromocytoma especially from anesthesiologist's perspectives.

Keywords: Beta-blockers; catecholamines; epinephrine; hypertension; magnesium sulphate; nor-epinephrine; phenoxybenzamine; pheochromocytoma.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Manger WM, Gifford JW., Jr . Pheochromocytoma: A clinical overview. In: Swales JD, editor. Textbook of Hypertension. Oxford: Blackwell Scientific; 1994. pp. 941–58.
    1. Greene JP. New perspectives in pheochromocytoma. Urol Clin North Am. 1989;16:487–503. - PubMed
    1. Khairi MR, Dexter RN, Burzynski NJ, Johnston CC. Mucosal neuroma, pheochromocytoma and medullary thyroid carcinoma: Multiple endocrine neoplasia type 3. Medicine. 1975;54:89–112. - PubMed
    1. Mihai R, Farndon JR. Familial endocrine disease– geneticsand early treatment. In: Farndon JR, editor. A Companion to Specialist Surgical Practice. Breast and Endocrine Surgery. Vol. 5. London: W.B. Saunders; 1997. pp. 113–42.
    1. Kaufman BH, Telander RL, van Heerden JA, Zimmerman D, Sheps SG, Dawson B. Pheochromocytoma in the paediatric age group:Current status. J Pediatr Surg. 1983;18:879–84. - PubMed